🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The project is primarily aimed at identifying and subsequently validating t...
Status
Unknown
Location
University of Pisa
Start Date
2021-11-01
Trial ID
NCT05301465
The purpose of this study is to determine if participants with metastatic c...
Status
Completed
Location
ImClone Investigational Site
Start Date
2010-08
Trial ID
NCT01111604
Treatments Being Tested
The main purpose of this study is to evaluate the safety of the study drug ...
Status
Completed
Location
Childrens Hospital of Alabama
Start Date
2015-12-11
Trial ID
NCT02564198
Treatments Being Tested
This phase II trial studies how well ramucirumab and paclitaxel or the FOLF...
Status
Recruiting
Location
Anchorage Associates in Radiation Medicine
Start Date
2020-06-01
Trial ID
NCT04205968
The main purpose of this study is to evaluate the safety and efficacy of th...
Status
Completed
Location
Highlands Oncology Group
Start Date
2015-07-13
Trial ID
NCT02426125
Treatments Being Tested
This is a single-arm phase I/Ib study of crenolanib combined with ramucirum...
Status
Completed
Location
Memorial Sloan Kettering Cancer Center
Start Date
2017-04-14
Trial ID
NCT03193918
Treatments Being Tested
This phase II LUNG-MAP treatment trial studies how well sapanisertib and do...
Status
Withdrawn
Location
Multiple Locations
Start Date
2020-09-05
Trial ID
NCT04267913
Treatments Being Tested
RATIONALE: Drugs used in chemotherapy, such as irinotecan hydrochloride, wo...
Status
Completed
Location
UAB Comprehensive Cancer Center
Start Date
2011-01-18
Trial ID
NCT01079780
Treatments Being Tested
This study is an open-label, international, multi-center, Phase 1 study in ...
Status
Terminated
Location
Mayo Clinic
Start Date
2023-08-10
Trial ID
NCT05980416
Treatments Being Tested
The purpose of this study was to evaluate the efficacy of derazantinib mono...
Status
Terminated
Location
AdventHealth Cancer Institute
Start Date
2020-10-06
Trial ID
NCT04604132